#

Pharmaceutical Companies

: 138
Novo Nordisk shares fell after the company reported disappointing sales results for its weight-loss drug / Photo: Shutterstock.com / Kittyfly
News·
Weak sales of Wegovy overshadowed Novo's "clearly less-than-impressive" forecast revision
Shares of AstraZeneca, a British biopharmaceutical giant, fell nearly 7%. Photo: Mats Wiklund/Shutterstock
News·
AstraZeneca shares plummeted following news of a mega-deal with Bristol Myers
The failure of Novo Nordisks drug trials sent its stock tumbling 10% / Photo: JHVEPhoto / Shutterstock
News·
Novo Nordisk shares plummeted 10% after a heart drug trial failed
Novo Nordisk shareholders have succeeded in securing the launch of a judicial investigation into the results of testing for the drug CagriSema / Photo: gguy / Shutterstock
News·
Novo Will Sue Investors Over the Results of a Study on a Weight-Loss Drug
Hedge funds have increased their exposure to healthcare stocks to a nearly five-year high
News·
Hedge funds have increased their exposure to healthcare stocks to a nearly five-year high
Profits at British pharmaceutical giant AstraZeneca exceeded analysts expectations last quarter. Photo: Konektus Photo/Shutterstock
News·
Oncology drugs helped boost AstraZeneca's profits by 21%. Will the company expand its portfolio?
Pharmaceutical giant Eli Lilly is a shareholder of Scribe / Photo: sasirin pamai / Shutterstock
News·
IPO Scribe: Shares in a biotech company backed by Eli Lilly and Sanofi are now available
The transaction gives Eli Lilly access to AtaiBeckley’s experimental drug being studied in phase III clinical trials for treatment-resistant depression / Photo: Shutterstock.com / Tada Images
News·
+1
·
Eli Lilly officially to acquire psychedelics drugmaker AtaiBeckley for $3.8 bln
Biogen shares fell following the release of results from Phase 2 trials of an Alzheimers drug / Photo: Shutterstock.com / JHVEPhoto
News·
Biogen shares fell after disappointing data on its Alzheimer's drug
Anthropic unveiled Claude Science, an AI platform for scientific research, and also announced the launch of preclinical drug development programs. Photo: Ousa Chea / Unsplash.com
Review·
Anthropic will focus on drug development. How can one profit from AI in the pharmaceutical sector?
Nike will release its quarterly results after the markets close on June 30 / Photo: Unsplash/Craig Lovelidge
News·
Morning in New York: Nike's Earnings Report and Negotiations Over the Strait of Hormuz Take Center Stage
Abivax Biotech Soars 36%: New Tests Allay Investors Fears / Photo: Abivax.com
News·
Abivax shares soared 36%. The company dispelled concerns about a cancer-causing drug
Load more